GPER1 and Alzheimer disease: We also investigated the interaction of AD susceptibility genes with ESR1 and ESR2, key targets of menopause hormone replacement drugs, as well as GPER1. Our findings underscore significant molecular distinctions between sexes, revealing sex-specific alterations in signaling pathways associated with AD.